BioSpace News Archive

CPhI & P-MEC India – organised by Informa Markets – is set to welcome attendees and exhibitors from around the world, both online and in-person, as new CPhI analysis points to sustained pharma growth in India, with an improving outlook for finished dosage, API and biologics.

Regulus Therapeutics Inc. (Nasdaq: RGLS), today announced that it will report financial results and highlights for the quarter ended September 30, 2021 on Wednesday, November 10, 2021, after the U.S. financial markets close.

Nyxoah Announces Participation in the Stifel 2021 Virtual Healthcare Conference Mont-Saint-Guibert, Belgium. – November 3, 2021, 10:30 pm CET / 4:30 pm ET

Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company, today announced third quarter 2021 financial results.

Surgalign Spine Technologies, today announced it plans to release financial results from the third quarter 2021 after the close of trading on November 9, 2021.

BioSTL launched The Center for Rural Health Innovation, a new Center of Excellence, to strengthen the health and economic vitality of rural communities through innovation and coalition building.

Solv4U is a new business area that opens Marinomed´s proprietary Marinosolv technology for external partners in technology partnerships.

Exelixis, Inc. (Nasdaq: EXEL) today announced that members of the company’s management team will participate in fireside chats at the following virtual investor conferences in November and December of 2021:

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced results for the third quarter and first nine months of 2021.

Guardant Health, Inc., a leading precision oncology company, and The Royal Marsden NHS Foundation Trust, one of the United Kingdom’s leading cancer research organizations, have agreed to enter into a partnership to establish an in-house liquid biopsy testing service using Guardant Health’s industry-leading proprietary digital sequencing platform.